Background: Proteinase activities are often measured using chromogenic substrates that are much smaller than physiological substrates. Methods: The hydrodynamic size of macromolecular substrates (macrosubstrates) prepared by linking small chromogenic substrates to polyethylene glycol was determined by gel filtration. Efficiency of macrosubstrate cleavage by proteinases and ␣ 2 -macroglobulin-proteinase complexes was monitored spectrophotometrically. Results: Macrosubstrates had hydrodynamic radii of ϳ20 Å, similar to proteins with a molecular weight of 18 000. Different macrosubstrates served as efficient substrates for chymotrypsin, trypsin, and thrombin. Linking small substrates to a polymer variably affected substrate efficiency, with the impact on activity ranging from a 60-fold decrease to a 30-fold increase. Proteinases complexed with ␣ 2 -macroglobulin had ϳ10-fold lower activity vs macrosubstrates than small substrates. Conclusions: Macrosubstrates are efficient substrates that allow decreased measurement of sterically hindered proteinase molecules such as ␣ 2 -macroglobulinproteinase complexes. Thus, macrosubstrates may provide more accurate functional assays of proteinases such as coagulation factors.
Small peptide substrates have contributed greatly to understanding the catalytic function of proteases, beginning with studies in Emil Fischer's laboratory in the early 1900s (1 ) and continuing with studies of peptide esters through the 1950s (2) (3) (4) . The development of 4-nitroanilide (4-NA) 3 substrates (5-7 ) provided greatly improved tools for protease measurements that allowed continuous spectrophotometric monitoring of reactions. The discovery that substrate cleavage by some proteinases was affected by the sequence of several residues in the substrate preceding the site of cleavage (7) (8) (9) (10) (11) opened the way to developing substrates that were relatively specific for assaying particular proteinases. Changes in the amino acid residues located two to four positions before the sites of cleavage can change the affinity and rates of cleavage of a substrate by particular proteases Ͼ1000-fold. The search for optimal small peptide substrates has led to hundreds of highly sensitive and relatively specific chromogenic and fluorogenic substrates for proteinases (12) (13) (14) (15) (16) (17) .
A major drawback of peptide substrates for measuring the activity of physiological proteinases such as components of the coagulation, complement, and fibrinolytic pathways, however, is that the substrates do not reproduce the size of the natural substrates, which are proteins. Small synthetic substrates may be cleaved by proteinases that cannot easily access physiological protein substrates because of complexing of the proteinase with other components, such as cofactors, inhibitors, binding proteins, antibodies, or surfaces. A major pathway for proteinase inactivation is by entrapment within the inhibitor ␣ 2 -macroglobulin (␣ 2 -M), which does not block the active site or peptidase activity of proteinases bound to it (18 -24 ) . The peptidase activity of proteinases entrapped within ␣ 2 -M interferes with measurement of the proteinase activity with small substrates. As a result of these factors, measurements of peptidase activity using small peptide substrates can differ substantially from functional proteinase activity, and this has been recognized as a major problem for assays of proteinases in plasma specimens (23, 24 ) .
There are several approaches to overcome this shortcoming and to measure proteinase action on protein substrates. Some of the earliest methods for measuring proteinase activity analyzed the cleavage of proteins such as casein or hemoglobin (25, 26 ) , and pepsin activity still is occasionally expressed in units of hemoglobin hydro-lysis and plasmin activity as casein units. However, these activity measurements are relatively nonspecific, measure only endpoints, require physical separation steps, and are hard to define kinetically because there are multiple potential sites of cleavage, each with different kinetic properties. For many physiological proteinases, it is possible to measure functional activity in clotting, fibrinolysis, or complement activation, but these assays involve complex multistep reactions.
In the present study, we synthesized and evaluated synthetic macromolecular substrates that had a large molecular size but still offered continuous monitoring and defined cleavage specificity of small chromogenic peptide substrates.
Materials and Methods materials
Bovine chymotrypsin and trypsin were purchased from Worthington Biochemicals. Active ␣ 2 -M was obtained from Calbiochem. The substrates S-2288 (d-Ile-Pro-Arg-4-NA) and S-2238 [d-Phe-pipecolic acid (Pip)-Arg-4-NA] were purchased from DiaPharma Group, Inc. Sarcosyl (Sar)-Pro-Arg-4-NA, carbobenzoxy (CBZ)-Lys-Arg-4-NA, Glu-Gly-Arg-4-NA, Gly-Arg-4-NA, and Arg-4-NA were from Bachem Bioscience. Human thrombin was from Sigma or from Enzyme Research Laboratory. Polyethylene glycol (PEG), PEG bis(amine) (M r 3400), succinyl-AlaAla-Pro-Phe-4-NA, 4-amidinophenylsulfonyl fluoride, Sephadex G-25 coarse, 4-nitrophenyl-4Ј-guanidinobenzoic acid, a standard solution of 4-nitrophenol, and proteins used as molecular weight calibrators were obtained from Sigma. Bio-Gel P-6 and P-60 were from Bio-Rad. Methoxypolyethylene glycol (mPEG) derivatives (mPEG-CH 2 -CH 2 -CO-N-hydroxysuccinimide and mPEG-O-COhydroxybenzotriazole esters) were obtained from Shearwater Polymers. The percentage of substitution of each mPEG with active ester was determined by the manufacturer, using nuclear magnetic resonance spectroscopy, to be Ն95% for all products except the hydroxybenzotriazole carbonate ester of M r 2000 mPEG, for which the substitution was 89%.
preparation of peg-substrate conjugates
Coupling of mPEG derivatives was performed by dissolving substrate to a concentration of ϳ100 mmol/L in 2 mL of dimethylformamide containing 100 g/L N-ethylmorpholine and adding 0.5-1.0 molar-equivalent of mPEG active ester. Reactions were incubated for 2 h at room temperature, and then diluted with 2 mL of water; product was isolated in the void volume of a 2.5 ϫ 15 cm Sephadex G-25 (coarse) column in 1 g/L acetic acid. Products were lyophilized to a dry powder, and absorbance measurements at 342 nm indicated a typical content of 4-NA of ϳ80% expected from dry weight, indicating a degree substitution of products Ն80%, with the remainder being free mPEG or associated water.
Other products were prepared by coupling reactions with diisopropylcarbodiimide using ratios of reactants to yield predominantly monofunctional products, although the PEGs used for these reactions contained two potential coupling sites. Monofunctional products were desired to avoid mixtures of mono-and bifunctional products that might not have exactly the same kinetic properties as substrates. Succinyl-Ala-Ala-Pro-Phe-4-NA (46 mg) in 0.5 mL of dimethylformamide was activated with 0.1 mol/L diisopropylcarbodiimide for 10 min at room temperature and mixed with 150 mg of PEG bis(amine) in 0.5 mL of dimethylformamide. After 1 h, the reaction mixture was chromatographed on a Bio-Gel P-6 column in 0.1 mol/L ammonium acetate, pH 6.0, and product was collected in the void volume. bis-Succinimide PEG was prepared by the action of succinic anhydride on PEG bis(amine). The bis-succinimide derivative was activated with diisopropylcarbodiimide and coupled with substrates containing free amino groups, such as S-2288 and S-2238. Products were isolated by chromatography on Bio-Gel P-6. Acetylation of S-2238 was performed with acetic anhydride.
molecular size analysis
Size exclusion chromatography was performed with a 2.5 ϫ 26 cm Bio-Gel P-60 column monitored by spectrophotometric analysis of column fractions. The buffer was 0.1 mol/L ammonium acetate. Calibration is described in the legend of Fig. 1 . Hydrodynamic sizes of macrosubstrates were estimated by comparison with protein calibrators under nondenaturing conditions, where there is a linear relationship of log molecular weight vs K AV , the partition coefficient of molecules on the column.
where V e , V o , and V i are the elution, void, and included volumes of the column.
enzyme assays
Measurements of protease activity at 37°C were performed and analyzed as described previously (27 ) with a Cobas FARA analyzer (Roche Diagnostic Systems). All assay buffers contained 10 g/L PEG. Thrombin assays were performed in 140 mmol/L NaCl, 10 mmol/L HEPES, pH 7.4. Chymotrypsin and trypsin assays were performed in 10 mmol/L CaCl 2 , 100 mmol/L Tris, pH 7.8.
Reactions had a total volume of 100 L and were monitored at 405 or 410 nm. Initial rates of reactions were evaluated with Lineweaver-Burk plots. Substrate solutions were prepared in either water for thrombin and trypsin substrates or in 500 mL/L dimethylformamide for succinyl-Ala-Ala-Pro-Phe-4-NA. Substrate concentrations were determined by absorbance at 342 nm, using a molar absorptivity of 8260, and concentrations were confirmed by absorbance at 410 nm after substrate hydrolysis, using a molar absorptivity of 8600 for the 4-NA product (28 ) . Active site titration of thrombin was performed using 4-nitrophenyl-4Ј-guanidinobenzoic acid with standardization of the absorbance of 4-nitrophenol under reaction conditions using a standard solution of 4-nitrophenol. Preincubation of enzymes with ␣ 2 -M was at 37°C. The 
Results

synthesis and size analysis of macrosubstrates
Covalent coupling of three 4-NA substrates, succinyl-AlaAla-Pro-Phe-4-NA, d-Phe-Pip-Arg-4-NA, and d-Ile-ProArg-4-NA (M r ϳ500), to PEG derivatives (M r 3400) yielded products with a much larger hydrodynamic size than the substrate alone. Analysis of three macrosubstrates by gel filtration on a Bio-Gel P-60 column (Fig. 1,  solid lines) showed that each eluted slightly after chymotrypsinogen (M r 24 000) and soybean trypsin inhibitor (M r 20 000). The calibration plot indicated that the hydrodynamic size of each conjugate was comparable to a protein of M r ϳ18 000 (Fig. 1D ), corresponding to an effective radius in solution of ϳ20 Å (29 ) . There was a single major peak preceded by a minor component that may represent dimers of the PEG derivative. The peptide and PEG components of the macrosubstrates were joined by stable amide bonds that were stable in aqueous solution, and no free substrate was detectable. The elution positions of the free substrates are shown in Fig. 1 as dashed lines from parallel runs.
It was not possible to estimate the hydrodynamic sizes of the free substrates because they adsorbed weakly on the column and eluted in a volume slightly greater than the column volume. The adsorption of the free substrates reflects the hydrophobic character of 4-NA substrates, which in some cases require organic solvents such as dimethyl sulfoxide to prepare concentrated stock solutions. The vastly different elution volumes of macrosubstrates and their peptidyl-4-NA components during gel filtration provided a simple means of purifying the macrosubstrates after reactions and obtaining material that was completely free of uncoupled substrate for kinetic analysis of substrate activity. The analyses in Fig. 1 confirmed that there was no unconjugated substrate in products. A favorable property of the macrosubstrates is high solubility in water, reflecting the dominance of the PEG component on the physical characteristics of the macrosubstrate. The size estimates of macrosubstrates were consistent with previous estimates of the size of free PEG (30, 31 ) . PEGs have an extended random coil structure with a relatively large hydrodynamic size per molecular weight compared with globular proteins (30 ) . This explains how a macrosubstrate with a PEG of only M r 3400 can model the size of a small globular protein of M r ϳ18 000.
kinetics of macrosubstrate cleavage
The kinetic properties of small 4-NA substrates were compared with macrosubstrates containing the same substrate sequences (Table 1) . Control reactions were performed with PEG derivatives without coupled substrates, and these were observed to have little effect on enzyme reactions. Addition of PEG derivatives to a concentration of 10 g/L caused only a 2-3% decrease in rates of substrate cleavage by trypsin or thrombin. The maximal rates of cleavage (V max ) of several substrates per molecule of chymotrypsin, trypsin, and thrombin decreased modestly when substrates were linked to PEG to form macrosubstrates. The affinity of enzymes for substrates was affected more substantially. The K m s of macrosubstrates, the concentrations yielding half-maximal rates, were higher than for the homologous free substrate: 1.7-fold higher for a chymotrypsin substrate, 1.4-and 4.2-fold higher for two trypsin substrates, and 2.4-and 6.2-fold higher for two thrombin substrates. Even with the drop in affinity, the K m s for all of the macrosubstrates were quite low, in the range of 12-110 mol/L.
Primarily as a result of the increase in K m , the efficiencies of these substrates decreased approximately two-to sixfold for proteinases such as trypsin and chymotrypsin, which have a relatively accessible catalytic site. Efficiency of cleavage of substrates by thrombin decreased by ϳ3-and 20-fold when a substrate was linked to PEG, possibly reflecting the greater steric hindrance of the thrombin active site (32 ) or its extended substrate specificity (7, (12) (13) (14) . Most of the substantial loss of efficiency in the action of thrombin on the substrate d-Phe-Pip-Arg-4-NA appeared to result from blockage of the N-terminal amino group, which is recognized to contribute to the efficiency of tripeptide thrombin substrates having d-amino acids at their NH 2 terminus (14 ) . Addition of an acetyl group to this substrate had an even greater effect than the addition of PEG. Optimization of macrosubstrates for thrombin will require reanalysis of structures. It is apparent that the presence or absence of a free NH 2 terminus on the third (P3) residue preceding the cleavage site has a major effect on substrate efficiency, and the type of group added to this amino acid residue is likely to exert a strong effect on substrate efficiency.
improved specificity of macrosubstrates for proteinase activity
We hypothesized that a major advantage of macrosubstrates relative to small chromogenic substrates would be the ability to distinguish between proteinase and peptidase activity. We examined this hypothesis using a model system that has been described in many previous reports (18 -24 ) . ␣ 2 -M binds to and entraps proteinases without blocking their catalytic sites. Consequently, protein substrates are sterically hindered from reaching catalytic sites and proteinase activity is nearly completely inhibited. Peptidase activity, however, is retained when peptide substrates with molecular weights Ͻ8000 are used because they are still able to reach the catalytic site. When increasing amounts of ␣ 2 -M were added to a fixed amount of chymotrypsin before activity measurements, activity measured with a chromogenic substrate was maximally inhibited by ϳ60% in the presence of excess ␣ 2 -M (Fig. 2) , indicating the residual peptidase activity of the inhibitorproteinase complex. Activity measured with the same substrate as a component of a macrosubstrate was inhibited by Ͼ95%. Analysis of the inhibition of trypsin and thrombin activity by ␣ 2 -M using pairs of substrates and macrosubstrates yielded similar results (Fig. 3) . Trypsin and thrombin activities measured with tripeptide substrates were inhibited only up to 40 -50% by excess inhibitor. The activities of macrosubstrates incorporating the same peptide sequences were inhibited Ͼ95%. These results provide clear evidence that the macrosubstrates selectively measured proteinase activity and that cleavage of these substrates by the peptidase activity trapped within ␣ 2 -M-proteinase complexes was greatly reduced. Reactivity of the macrosubstrates with ␣ 2 -M-proteinase complexes was decreased ϳ10-fold relative to free tripeptide substrates.
mPEG derivatives
Use of a monofunctional polymer carrier, mPEG, has several potential advantages over the use of PEG derivatives that have two potential sites for attachment of substrate groups: It assures that all macrosubstrate molecules have a single substrate group and that there are no complex cleavage kinetics resulting from variable mixtures of mono-and bifunctional substrates, the ratio of which would change during the course of an enzyme reaction. There are also practical advantages in that mPEG derivatives are commercially available with a greater range of sizes and activated linker groups for coupling to peptides. The size and chemical linkage of polymer to peptide components of macrosubstrates may have a large effect on substrate efficiency, hydrodynamic size, or steric hindrance of the substrate site.
A series of macrosubstrates containing mPEG derivatives were examined as thrombin substrates (Table 2) . These macrosubstrates, like the ones listed in Table 1 , exhibited simple saturation kinetics with linear Lineweaver-Burk plots (Fig. 4) . Addition of mPEG derivatives to substrates with one or two amino acid residues, Arg-4-NA and Gly-Arg-4-NA, produced substantial increases in substrate efficiency. However, the efficiencies of these substrates measured as k cat /K m were still more than 1000-fold less than efficient tripeptide substrates. The mPEG component did not fully substitute for the P3 amino acid residues that serve as critical determinants of the efficiency of substrates for thrombin. These macrosubstrates would serve as slow or low-efficiency substrates for monitoring large quantities of enzyme over longer periods of time. It appears necessary to incorporate tripeptide sequences, e.g., some of the products in Table 1 , to produce macrosubstrates with high affinity and rates of cleavage.
The size of the mPEG component did not have a strong influence on substrate efficiency because a macrosubstrate with a Gly-Arg-4-NA component had similar substrate efficiency whether the molecular weight of the mPEG component was 1000 or 5000. Linkage of Gly-Arg-4-NA to a lysine residue bearing mPEGs with a molecular weight of 5000 on both of its amino groups produced a substrate with substantially reduced affinity for thrombin, possibly because steric hindrance limited access to the substrate. Addition of mPEG to the sidechain of a lysine residue in the P2 position of CBZ-Lys-Arg-4-NA yielded a branched product that was Ͼ30-fold more efficient than the original substrate, which was an extremely poor thrombin substrate. Addition of mPEG to the tripeptide substrate Glu-Gly-Arg-4-NA, which also is a poor thrombin substrate, had little effect on substrate efficiency, whereas addition of mPEG to Sar-Pro-Arg-4-NA, which is a good thrombin substrate, produced a Ͼ50-fold loss of efficiency. It is apparent that the influence of the addition of mPEG to small peptide substrates is highly variable depending on the individual substrates. In some cases, the substrate efficiency is increased and in others it is dramatically decreased. 
Discussion
This report describes macromolecular chromogenic substrates with a single defined cleavage specificity and simple reaction kinetics similar to those for small substrates. The macrosubstrates have a hydrodynamic size comparable to a small protein, and it is possible to generate substrates of various sizes with the same cleavage specificity by varying the size of the polymeric component. This may allow analysis of the effect of substrate size independent of other variables. It should be possible to produce macrosubstrates for most endoproteinases and to generate macrosubstrates with a variety of fluorogenic or chromogenic groups in addition to the 4-NA chromophore. Polymers other than PEG or mPEG might be adapted to serve as the polymeric components of macrosubstrates. However, PEG and mPEG derivatives have several highly favorable attributes, as summarized by Harris (33 ) . PEGs and mPEGs are inert, uncharged polymers that assume extended random-coil structures with a high excluded volume per molecular weight, and the polymer is highly soluble in water and in organic solvents that are favorable for peptide coupling and derivatization. The wide range of commercially available polymer sizes and activated derivatives allows the preparation of a wide range of structures. A final critical point concerning the suitability of PEGs and mPEGs as components of macrosubstrates is that the high substrate efficiency of some macrosubstrates indicates that the polymeric component does not envelope or severely limit access of proteases to the substrate component. Use of macrosubstrates should better model the steric factors that affect the action of many physiological proteinases, such as complement, fibrinolytic, and coagulation factors, where the natural substrates are proteins of substantial size. The ability to selectively measure proteinase rather than peptidase activity may provide, in particular, more accurate measures of the functional activity of proteinases in serum or plasma, where ␣ 2 -M can inhibit proteinase activity without blocking the active sites of proteinases. ␣ 2 -M has been reported to interfere with efforts using chromogenic substrates to directly measure proteinase activity in plasma (23, 24 ) , and this is a general problem with measuring proteinase activity in serum or plasma. By avoiding this interference, macrosubstrates may substantially improve the performance of chromogenic assays for measuring functional activities of coagulation factors, fibrinolytic components, complement factors, inhibitors of physiological proteinases, and cofactors of inhibitors such as heparin. There are many other circumstances, in addition to complexing with ␣ 2 -M, where catalytically active proteinase molecules could have reduced proteinase activity relative to peptidase activity because they are complexed with antibodies, surfaces, or other factors. In these circumstances, macrosubstrates would provide better measures of functional proteinases than small chromogenic substrates. The PEG component of macrosubstrates also may serve as a highly effective protecting group against exopeptidase action to assure that only endoproteinase activity is measured.
The ability to synthesize macrosubstrates with branched structures where the polymeric component is linked to an amino acid sidechain may be useful in examining the steric hindrance of particular substrate positions for specific target enzymes. This modification together with structural variation in linker chemistries and polymer size offers a wide range of structural variation that may serve as additional determinants for making substrates that are more specific for the measurement of different proteinases. Furthermore, the specificities of many proteinases for their physiological substrates are determined by binding interactions of substrates with exosites that are separate from the catalytic sites of enzymes. It may be possible to develop macrosubstrates of much higher target specificity by making bifunctional substrates in which one end mediates binding to an exosite and the other serves as a substrate for the catalytic site. The polymeric component of a macrosubstrate would then serve as a spacer to connect these two components. Several heterobifunctional derivatives of PEG are available that would allow selective coupling of different functional groups to opposite ends of PEG chains.
In conclusion, the development of chromogenic substrates of substantial size may be useful in the development of immunoinhibition assays of specific proteinases or in efforts to discover new inhibitors of proteinases. Use of substrates of large physical size may enhance the steric hindrance produced by the binding of antibodies, aptamers, or other molecules to enzymes and expand the target zone of inhibition to additional epitopes or binding sites that are neighboring but not immediately part of the active site.
